HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naohiro Kanayama Selected Research

Amniotic Fluid Embolism

1/2021Fibrinogen may aid in the early differentiation between amniotic fluid embolism and postpartum haemorrhage: a retrospective chart review.
12/2020Consumptive Coagulopathy Involving Amniotic Fluid Embolism: The Importance of Earlier Assessments for Interventions in Critical Care.
1/2020Acute inflammation in the uterine isthmus coincides with postpartum acute myometritis in the uterine body involving refractory postpartum hemorrhage of unknown etiology after cesarean delivery.
12/2017Squamous cell carcinoma antigen as a novel candidate marker for amniotic fluid embolism.
12/2017Value of fibrinogen in cases of maternal death related to amniotic fluid embolism.
4/2017Amniotic fluid embolism: Pathophysiology from the perspective of pathology.
7/2015Therapeutic application of C1 esterase inhibitor concentrate for clinical amniotic fluid embolism: a case report.
1/2015Successful resuscitation of amniotic fluid embolism applying a new classification and management strategy.
6/2014C1 esterase inhibitor activity in amniotic fluid embolism.
4/2014Predictor of mortality in patients with amniotic fluid embolism.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naohiro Kanayama Research Topics

Disease

35Neoplasms (Cancer)
02/2021 - 08/2002
19Ovarian Neoplasms (Ovarian Cancer)
02/2012 - 08/2002
14Neoplasm Metastasis (Metastasis)
11/2005 - 03/2003
11Amniotic Fluid Embolism
01/2021 - 01/2011
8Pre-Eclampsia (Preeclampsia)
01/2021 - 12/2002
7Hemorrhage
01/2017 - 12/2002
6Disseminated Intravascular Coagulation
01/2021 - 01/2011
5Uterine Inertia
01/2020 - 01/2011
5Body Weight (Weight, Body)
05/2015 - 02/2004
5Carcinoma (Carcinomatosis)
06/2007 - 04/2003
5Chondrosarcoma
11/2005 - 03/2002
4Chorioamnionitis
01/2020 - 02/2006
4Inflammation (Inflammations)
01/2020 - 11/2004
3Thrombosis (Thrombus)
01/2018 - 09/2008
3Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
12/2015 - 01/2011
3Spontaneous Abortion (Miscarriage)
08/2015 - 09/2005
3Ascites
06/2007 - 05/2004
2Premature Birth (Birth, Premature)
03/2021 - 01/2014
2Endometrial Neoplasms (Endometrial Cancer)
07/2020 - 11/2002
2Anaphylaxis (Anaphylactic Shock)
01/2020 - 01/2014
2Leiomyoma (Uterine Fibroids)
07/2019 - 04/2010
2Maternal Death
12/2017 - 01/2011
2Thrombocytopenia (Thrombopenia)
07/2017 - 12/2002
2Seizures (Absence Seizure)
04/2017 - 12/2002
2Hypoxia (Hypoxemia)
04/2017 - 01/2004
2Rupture
08/2015 - 06/2010
2Hypertension (High Blood Pressure)
06/2015 - 12/2002
2Birth Weight (Birth Weights)
05/2015 - 02/2014
2Heart Arrest (Cardiac Arrest)
01/2015 - 04/2014
2Acute Liver Failure (Fulminant Hepatic Failure)
03/2012 - 04/2003
2Pulmonary Embolism
01/2011 - 08/2005
2Necrosis
10/2009 - 11/2008
2Thrombophilia
08/2005 - 06/2005
2Proteinuria
06/2005 - 12/2002
1Hypothermia
07/2022
1Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2021
1Leukemia
02/2021
1Stomach Neoplasms (Stomach Cancer)
02/2021
1Abruptio Placentae (Placental Abruption)
01/2021

Drug/Important Bio-Agent (IBA)

15Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2005 - 03/2002
13Proteins (Proteins, Gene)FDA Link
11/2005 - 08/2002
12Protease Inhibitors (Protease Inhibitor)IBA
11/2004 - 03/2002
11Messenger RNA (mRNA)IBA
11/2005 - 08/2002
7Dacarbazine (DIC)FDA LinkGeneric
01/2021 - 01/2011
7ThrombinFDA Link
01/2017 - 12/2002
7CytokinesIBA
12/2005 - 04/2003
6AntithrombinsIBA
01/2021 - 12/2002
6Transforming Growth Factor beta1 (TGF beta 1)IBA
11/2005 - 07/2003
5Complementary DNA (cDNA)IBA
04/2004 - 04/2003
4Fibrinogen (Factor I)FDA Link
01/2021 - 01/2011
41-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2018 - 06/2007
4Photosensitizing Agents (Photosensitizers)IBA
01/2018 - 06/2007
4Plasminogen Activator Inhibitor 1IBA
01/2017 - 12/2002
4Trypsin InhibitorsIBA
12/2005 - 01/2004
4Urokinase Plasminogen Activator ReceptorsIBA
04/2004 - 08/2002
3Indicators and Reagents (Reagents)IBA
01/2020 - 09/2004
3Singlet OxygenIBA
01/2018 - 11/2008
3FibrinIBA
01/2018 - 06/2005
3Hyaluronic Acid (Hyaluronan)IBA
04/2010 - 08/2002
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2005 - 11/2004
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2005 - 12/2002
3Phosphotransferases (Kinase)IBA
11/2004 - 12/2002
3Plasminogen InactivatorsIBA
10/2004 - 07/2003
2Hemoglobins (Hemoglobin)IBA
12/2020 - 06/2015
2Biomarkers (Surrogate Marker)IBA
12/2020 - 03/2005
2Complement System Proteins (Complement)IBA
01/2020 - 06/2014
2Kallikreins (Kallikrein)IBA
08/2019 - 06/2014
2KininsIBA
08/2019 - 06/2014
2SteroidsIBA
01/2018 - 01/2014
2Oxygen (Dioxygen)IBA
04/2016 - 03/2007
2Amlodipine (Norvasc)FDA LinkGeneric
12/2015 - 05/2015
2Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA
07/2015 - 06/2014
2Interleukin-8 (Interleukin 8)IBA
04/2014 - 01/2014
2AntigensIBA
07/2013 - 04/2007
2EpitopesIBA
02/2012 - 03/2002
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2011 - 08/2005
2Protein CIBA
01/2011 - 08/2005
2Liposomes (Liposome)IBA
11/2008 - 06/2007
2SolutionsIBA
11/2008 - 02/2004
2Thalidomide (Thalomid)FDA Link
11/2005 - 05/2005
2OligodeoxyribonucleotidesIBA
08/2005 - 10/2004
2Insulin-Like Growth Factor I (IGF-1)IBA
08/2005 - 04/2004
2Cyclin-Dependent Kinases (cdk Proteins)IBA
06/2005 - 12/2002
2LipopolysaccharidesIBA
03/2005 - 04/2003
2Glycoproteins (Glycoprotein)IBA
03/2005 - 08/2002
2EnzymesIBA
03/2005 - 12/2002
2A-factor (Streptomyces)IBA
09/2004 - 07/2003
2Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA
04/2004 - 04/2003
2matriptaseIBA
04/2004 - 04/2003
2Tyrosine (L-Tyrosine)FDA Link
04/2003 - 08/2002
1Biological ProductsIBA
02/2021

Therapy/Procedure

7Therapeutics
07/2022 - 04/2007
5Hysterectomy
02/2021 - 12/2016
5Cesarean Section (Caesarean Section)
01/2020 - 12/2002
5Photochemotherapy (Photodynamic Therapy)
01/2018 - 06/2007
4Drug Therapy (Chemotherapy)
02/2021 - 03/2005
3Lasers (Laser)
11/2008 - 06/2007
2Cervical Cerclage
03/2021 - 08/2015
2Oral Administration
01/2021 - 02/2004
2Ligation
12/2002 - 08/2002